Effect of Oral Ibuprofen in Bone Marrow Biopsy Pain

The Study of Oral Ibuprofen Effect on Pain , anxiety and Physiological Indexes in Patients Undergoing Bone marrow Biopsy in kowsar hospital from 2019 to 2020

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181009041284N1

Enrollment

Registered

2020-09-28

Start date

2020-03-10

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and anxiety and physiological parameters during bone marrow biopsy and aspiration. Disease of blood and blood-forming organs, unspecified

Interventions

Intervention 1: Intervention group:One hour before the procedure, the patient receives one 400 mg ibuprofen tablet orally. The number of drugs is one and a single dose.This method of drug therapy is t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Satisfaction of the patient to participate in the plan Compelete consciousness Be in the adult age category (over 18 years old)

Exclusion criteria

Exclusion criteria: Taking sedative drug and opioid History of asthma, urticaria, and any hypersensitivity reactions to non-steroidal anti-inflammatory drugs and aspirin Pacemaker Third trimester of pregnancy or lactation Active liver disease Brain bleeding or other active bleeding Uncontrolled heart failure Inflammatory bowel disease Thrombocytopenia

Design outcomes

Primary

Measure	Time frame
Pain score at visual analogue scale questionnaire. Timepoint: After the end of the procedure. Method of measurement: Visual analogue scale questionnaire.;Anxiety score at clinical Global Impression questionnaire. Timepoint: After the end of the procedure. Method of measurement: Clinical Global Impression questionnaire.;The amount of blood pressure. Timepoint: Before the intervention, the second minute, the fourth minute, the end of the intervention. Method of measurement: Mercury sphygmomanometer.;Heart rate. Timepoint: Before the intervention, the second minute, the fourth minute, the end of the intervention. Method of measurement: Cardiac monitoring device.;Percentage of blood oxygen saturation. Timepoint: Before the intervention, the second minute, the fourth minute, the end of the intervention. Method of measurement: Pulse Oximeter.	—

Measure

Time frame

Pain score at visual analogue scale questionnaire. Timepoint: After the end of the procedure. Method of measurement: Visual analogue scale questionnaire.;Anxiety score at clinical Global Impression questionnaire. Timepoint: After the end of the procedure. Method of measurement: Clinical Global Impression questionnaire.;The amount of blood pressure. Timepoint: Before the intervention, the second minute, the fourth minute, the end of the intervention. Method of measurement: Mercury sphygmomanometer.;Heart rate. Timepoint: Before the intervention, the second minute, the fourth minute, the end of the intervention. Method of measurement: Cardiac monitoring device.;Percentage of blood oxygen saturation. Timepoint: Before the intervention, the second minute, the fourth minute, the end of the intervention. Method of measurement: Pulse Oximeter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Foroozesh Fard

Semnan University of Medical Sciences

Mff45@yahoo.com+98 23 31420

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026